PE targets opportunities in nutraceuticals: 7 deals

Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector.

ByJohn R Fischer

14 August 2026•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured Europe North America UK US Western Europe Healthcare Top Stories